The antibody lecanemab is the first authorized therapy in Europe that targets the underlying process of Alzheimer's, rather than only treating symptoms.

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

The link between air pollution and cognition is clear, with evidence showing pollutants affect brain development and increase neurodegenerative disease risk.

CRISPR revealed new genes that may influence Parkinson's disease risk. (Science) The Alzheimer's Disease Research Center and ...

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

Researchers developing benchmarks for a blood-based test like those for measuring blood glucose and cholesterol ...

There's new research linking senolytics to helping slow down Alzheimer's progression. Here's how and what experts have to say ...

Panelists discuss how hesitancy in prescribing amyloid-targeting therapies stems from multiple factors including concerns about ARIA adverse effects, modest clinical efficacy data, high treatment ...

CERN’s LHCb experiment confirms CP violation in baryons, marking a milestone in particle physics; Japan unveils the world’s ...

The woman’s brain was donated to research after her death, and it was analyzed by researchers for signs of Alzheimer’s ...

Quest Diagnostics (DGX) launched a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer’s ...